Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06630208
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
Effectiveness of Myofascial Release in Patients With Chronic Post Sternotomy Pain Syndrome
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effectiveness of Myofascial Release in Patients With Chronic Post Sternotomy Pain Syndrome
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main aim of this study is to investigate the effectiveness of Myofascial release in patients with chronic sternotomy pain
Detailed Description:
Post-sternotomy pain syndrome PSPS is a prevalent disorder affecting a substantial proportion of patients who have undergone sternotomy surgery with incidence rates ranging from 10 to 40 Several mechanisms have been proposed to be responsible for the development of PSPS for example intercostal neuralgia from scar-entrapped neuroma brachial plexus injury ribs or costal fractures with incomplete healing sternal wound infections and even hypersensitivity reaction to sternal wire chronic post sternotomy pain CPSP can compromise quality of life affecting their sleep patterns and impairing their working ability
During the first week after coronary artery bypass grafting CABG surgery vital capacity VC decreases by 30-60 and even up to 1 year this remains reduced by 12 Reduced VC has a negative effect on exercise tolerance Vo2max and therefore it is important to optimize pulmonary function after CABG surgery The decreased thoracic mobility after CABG still presents 12 months after surgery Thoracic mobility and vital capacity were affected more when the left internal thoracic artery LITA-retractor was used and reduced thoracic mobility is related to diminished pulmonary function
New therapeutic-rehabilitative proposals have been tried in cardiac patients After cardiac surgery it was found that the responses of the cardiovascular and respiratory systems get better after neuromuscular manual therapy The strong correlation between manual therapy and its effects suggests that a central control mechanism could be activated by manual therapy
Using Myofascial release MFR techniques may be beneficial for patients post-CABG and off-pump coronary artery bypass grafting OPCAB surgery The advantages of MFR techniques are gentleness and non-invasiveness During therapy one works with fascia structures thus not influencing bone structures directly These techniques are comfortable and safe they may be applied in acute conditions
During the first week after coronary artery bypass grafting CABG surgery vital capacity VC decreases by 30-60 and even up to 1 year this remains reduced by 12 Reduced VC has a negative effect on exercise tolerance Vo2max and therefore it is important to optimize pulmonary function after CABG surgery The decreased thoracic mobility after CABG still presents 12 months after surgery Thoracic mobility and vital capacity were affected more when the left internal thoracic artery LITA-retractor was used and reduced thoracic mobility is related to diminished pulmonary function
New therapeutic-rehabilitative proposals have been tried in cardiac patients After cardiac surgery it was found that the responses of the cardiovascular and respiratory systems get better after neuromuscular manual therapy The strong correlation between manual therapy and its effects suggests that a central control mechanism could be activated by manual therapy
Using Myofascial release MFR techniques may be beneficial for patients post-CABG and off-pump coronary artery bypass grafting OPCAB surgery The advantages of MFR techniques are gentleness and non-invasiveness During therapy one works with fascia structures thus not influencing bone structures directly These techniques are comfortable and safe they may be applied in acute conditions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None